Ie−Ming Shih

13.1k total citations · 2 hit papers
112 papers, 6.1k citations indexed

About

Ie−Ming Shih is a scholar working on Molecular Biology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Ie−Ming Shih has authored 112 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 44 papers in Reproductive Medicine and 25 papers in Cancer Research. Recurrent topics in Ie−Ming Shih's work include Ovarian cancer diagnosis and treatment (41 papers), Gene expression and cancer classification (17 papers) and Endometrial and Cervical Cancer Treatments (15 papers). Ie−Ming Shih is often cited by papers focused on Ovarian cancer diagnosis and treatment (41 papers), Gene expression and cancer classification (17 papers) and Endometrial and Cervical Cancer Treatments (15 papers). Ie−Ming Shih collaborates with scholars based in United States, Taiwan and Japan. Ie−Ming Shih's co-authors include Kathleen R. Cho, Tian‐Li Wang, Robert J. Kurman, Russell Vang, Brant G. Wang, Christoph Lengauer, Bert Vogelstein, Gad Singer, Robert F. Oldt and R. J. Kurman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Ie−Ming Shih

112 papers receiving 6.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma

2003 667 citations Brant G. Wang, Ie−Ming Shih et al. profile →
Ovarian Cancer

2008 564 citations Ie−Ming Shih et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ie−Ming Shih United States	38	3.1k	2.1k	1.6k	1.5k	826	112	6.1k
Steve E. Kalloger Canada	44	2.7k 0.9×	2.8k 1.3×	1.4k 0.9×	1.7k 1.2×	869 1.1×	101	6.3k
Anthony N. Karnezis United States	41	4.2k 1.4×	2.0k 0.9×	1.5k 0.9×	2.4k 1.6×	1.1k 1.3×	90	7.9k
Elena Ioana Braicu Germany	40	2.1k 0.7×	2.3k 1.1×	1.2k 0.7×	1.7k 1.2×	300 0.4×	303	5.4k
Helen Mackay Canada	41	2.9k 0.9×	2.2k 1.0×	1.3k 0.8×	2.9k 1.9×	894 1.1×	185	7.1k
Daniel Rosen United States	37	2.6k 0.9×	1.0k 0.5×	1.0k 0.6×	1.5k 1.0×	395 0.5×	87	4.9k
Anne‐Marie Mes‐Masson Canada	50	4.4k 1.4×	1.2k 0.6×	1.9k 1.2×	2.7k 1.8×	639 0.8×	272	9.1k
Yinhua Yu United States	42	3.8k 1.2×	1.0k 0.5×	1.1k 0.7×	1.2k 0.8×	322 0.4×	82	5.8k
Stanley B. Kaye United Kingdom	35	3.2k 1.1×	1.5k 0.7×	949 0.6×	2.5k 1.7×	556 0.7×	102	6.1k
Amir A. Jazaeri United States	34	2.6k 0.8×	775 0.4×	1.8k 1.1×	2.3k 1.6×	559 0.7×	169	5.7k
Aurelia Noske Germany	38	3.2k 1.1×	661 0.3×	1.9k 1.2×	3.2k 2.1×	749 0.9×	102	6.8k

Countries citing papers authored by Ie−Ming Shih

Since Specialization

Citations

This map shows the geographic impact of Ie−Ming Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ie−Ming Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ie−Ming Shih more than expected).

Fields of papers citing papers by Ie−Ming Shih

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ie−Ming Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ie−Ming Shih. The network helps show where Ie−Ming Shih may publish in the future.

Co-authorship network of co-authors of Ie−Ming Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Ie−Ming Shih. A scholar is included among the top collaborators of Ie−Ming Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ie−Ming Shih. Ie−Ming Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Jiawei, Tien-Chin Chang, Yao Shen, et al.. (2025). Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment. Advanced Biology. 9(10). e00738–e00738. 2 indexed citations

Wu, Tzu-I, Rebecca L. Stone, Tian‐Li Wang, et al.. (2024). Salpingectomy for ectopic pregnancy reduces ovarian cancer risk—a nationwide study. JNCI Cancer Spectrum. 8(3). 1 indexed citations

Bons, Joanna, Meng‐Horng Lee, Pei-Hsun Wu, et al.. (2024). Combined assembloid modeling and 3D whole-organ mapping captures the microanatomy and function of the human fallopian tube. Science Advances. 10(39). eadp6285–eadp6285. 5 indexed citations

Liberto, Juliane, et al.. (2024). Dual Inhibition of SYK and EGFR Overcomes Chemoresistance by Inhibiting CDC6 and Blocking DNA Replication. Cancer Research. 84(22). 3881–3893. 2 indexed citations

Cope, Leslie, Chih‐Ming Ho, Amanda N. Fader, et al.. (2024). Single‐molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer. Clinical and Translational Medicine. 14(8). e1778–e1778. 2 indexed citations

Shih, Ie−Ming, et al.. (2023). ARID1A loss activates MAPK signaling via DUSP4 downregulation. Journal of Biomedical Science. 30(1). 94–94. 8 indexed citations

Tully, Ellen, Peng Huang, Philipp Oberdoerffer, et al.. (2023). Temozolomide Sensitizes ARID1A -Mutated Cancers to PARP Inhibitors. Cancer Research. 83(16). 2750–2762. 12 indexed citations

Wethington, Stephanie L., Payal D. Shah, Lainie P. Martin, et al.. (2023). C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer. Clinical Cancer Research. 29(15). 2800–2807. 40 indexed citations

Asaka, Shiho, Ying Liu, Yohan Suryo Rahmanto, et al.. (2023). ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis. Modern Pathology. 36(2). 100045–100045. 12 indexed citations

10.

Wang, Yeh, Christopher Douville, Yen‐Wei Chien, et al.. (2023). Aneuploidy Landscape in Precursors of Ovarian Cancer. Clinical Cancer Research. 30(3). 600–615. 7 indexed citations

11.

Hui, Pei, Fleur Webster, Rebecca N. Baergen, et al.. (2022). Dataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology. 41(Supplement 1). S34–S43. 4 indexed citations

12.

Wang, Yeh, Peng Huang, Brant G. Wang, et al.. (2022). Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis. Cancer Research. 82(24). 4528–4541. 27 indexed citations

13.

Hong, Jiaxin, Yao Shen, Chih‐Yi Hsu, et al.. (2022). Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC). Genes & Diseases. 9(6). 1408–1411. 12 indexed citations

14.

Shen, Yao, Jin Gyoung Jung, Geoffrey D. Shimberg, et al.. (2021). Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy. iScience. 24(11). 103297–103297. 17 indexed citations

15.

Shih, Ie−Ming, Joon Tae Park, A. Ayhan, et al.. (2016). Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1. Cancer Research. 76(21). 6351–6361. 62 indexed citations

16.

Herlinger, Alice Laschuk, Min Gao, Ren‐Chin Wu, et al.. (2016). Abstract A80: NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in ovarian cancer (OVCA).. Clinical Cancer Research. 22(2_Supplement). A80–A80. 2 indexed citations

17.

Sheu, Jim Jinn‐Chyuan, Jung‐Hye Choi, Fuu‐Jen Tsai, et al.. (2008). The Roles of Human Sucrose Nonfermenting Protein 2 Homologue in the Tumor-Promoting Functions of Rsf-1. Cancer Research. 68(11). 4050–4057. 48 indexed citations

18.

Cheng, Wen‐Fang, Chien‐Fu Hung, Chee‐Yin Chai, et al.. (2007). Generation and characterization of an ascitogenic mesothelin‐expressing tumor model. Cancer. 110(2). 420–431. 19 indexed citations

19.

Staebler, Annette, H Schmidt, Eberhard Korsching, et al.. (2006). Chromosomal losses of regions on 5q and lack of high‐level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma. Genes Chromosomes and Cancer. 45(10). 905–917. 23 indexed citations

20.

Shih, Ie−Ming, et al.. (1997). Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion.. PubMed. 57(17). 3835–40. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact